MH

Manoj Hemraj Dama

Director Director DIN 08386881
DIN 08386881 First appointment Feb 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2019
Shareholding value •••• Premium profile

About Manoj Hemraj Dama

Data last updated:

Manoj Hemraj Dama was a Director at Esehat Meditech Limited (2019–2023) and Director at Chenab Enterprise Private Limited (2019–2022). The companies operate in Healthcare and Engineering.

DIN 08386881
Primary Designation Director
Industry Healthcare
First Appointment 25 Feb 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Esehat Meditech Limited U74999MH2018PLC309344
Director25 Feb 20192018₹3.1 Lakh (FY 2025)Active
Chenab Enterprise Private Limited U51101MH2011PTC216579
Director15 Mar 20192011₹6.10 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Esehat Meditech Limited
Chenab Enterprise Private Limited
Premium access

Shareholding and investment profile for Manoj Hemraj Dama

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manoj Hemraj Dama

Manoj Hemraj Dama was first appointed on 25 Feb 2019 as Director at Esehat Meditech Limited.

Manoj Hemraj Dama held 2 earlier board appointments: Esehat Meditech Limited (Director, 25 Feb 2019 to 30 Sep 2023); Chenab Enterprise Private Limited (Director, 15 Mar 2019 to 23 Mar 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available